$52.79
-0.91-1.69%
At close: -
$52.79
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Disc Medicine Insider Trading Activity | NASDAQ:IRON | Benzinga
Track the latest Disc Medicine insider trading activity. Stay informed on recent buys, sells, and market impact for Disc Medicine stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Disc Medicine Inc Insiders Doing?
At Disc Medicine Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 729.63K shares worth $39.60M, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On February 20, 2025, Rahul Khara, the company's CHIEF LEGAL OFFICER sold 1.16K shares for $54.58 each.
- On February 20, 2025, YenWen Jonathan Yu, the company's CHIEF OPERATING OFFICER sold 1.61K shares for $54.58 each.
- On February 20, 2025, Jacob William Savage, the company's CHIEF MEDICAL OFFICER sold 1.64K shares for $54.58 each.
Ownership Statistics for Disc Medicine Inc
Shares Outstanding
34.569M
Insider Shares Owned
874.533K
Insider Percentage Owned
2.53%
Institutional Shares Held
12.211M
Institutional Percentage Held
35.3%
| Mar 21, 2025 | Mona Ashiya | DIRECTOR | -52.43K | $54.02 | -$2.83M | SELL | -21.87% | 187.30K | Mar 19 - Mar 21 | View |
| Mar 21, 2025 | ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLCOrbiMed Capital GP VIII LLCOrbiMed Genesis GP LLC | DIRECTOR | -52.43K | $54.02 | -$2.83M | SELL | -21.87% | 187.30K | Mar 19 - Mar 21 | View |
| Mar 12, 2025 | Mona Ashiya | DIRECTOR | -312.38K | $54.31 | -$16.97M | SELL | -61.66% | 194.21K | Mar 10 - Mar 12 | View |
| Mar 12, 2025 | ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLCOrbiMed Capital GP VIII LLCOrbiMed Genesis GP LLC | DIRECTOR | -312.38K | $54.31 | -$16.97M | SELL | -61.66% | 194.21K | Mar 10 - Mar 12 | View |
| Feb 20, 2025 | Pamela Stephenson | CHIEF COMMERCIAL OFFICER | -3.14K | $54.58 | -$171.22K | SELL | -4.32% | 69.53K | Feb 18 | View |
| Feb 20, 2025 | Rahul Khara | CHIEF LEGAL OFFICER | -1.16K | $54.58 | -$63.37K | SELL | -3.00% | 37.58K | Feb 18 | View |
| Feb 20, 2025 | Jacob William Savage | CHIEF MEDICAL OFFICER | -1.64K | $54.58 | -$89.40K | SELL | -2.34% | 68.50K | Feb 18 | View |
| Feb 20, 2025 | YenWen Jonathan Yu | CHIEF OPERATING OFFICER | -1.61K | $54.58 | -$87.87K | SELL | -3.82% | 40.55K | Feb 18 | View |
| Feb 20, 2025 | Jean Franchi | CHIEF FINANCIAL OFFICER | -3.14K | $54.58 | -$171.16K | SELL | -4.32% | 69.53K | Feb 18 | View |
| Feb 20, 2025 | John Quisel | CHIEF EXECUTIVE OFFICER | -5.57K | $54.58 | -$304.23K | SELL | -3.48% | 154.83K | Feb 18 | View |
| Feb 04, 2025 | Rahul Khara | CHIEF LEGAL OFFICER | 0.00 | $35.12 | -$306.40K | SELL-OPTIONS | 0.00% | 14.04K | Feb 03 | View |
| Jan 06, 2025 | Rahul Khara | CHIEF LEGAL OFFICER | 0.00 | $38.72 | -$360.48K | SELL-OPTIONS | 0.00% | 14.04K | Jan 02 | View |
| Jan 02, 2025 | John Quisel | CHIEF EXECUTIVE OFFICER | 10.00K | $33.98 | -$667.66K | SELL-OPTIONS | 13.88% | 82.06K | Dec 30 - Dec 31 | View |
| Dec 26, 2024 | John Quisel | CHIEF EXECUTIVE OFFICER | 0.00 | $32.89 | -$1.20M | SELL-OPTIONS | 0.00% | 72.06K | Dec 23 | View |
| Dec 18, 2024 | John Quisel | CHIEF EXECUTIVE OFFICER | 0.00 | $33.51 | -$831.40K | SELL-OPTIONS | 0.00% | 72.06K | Dec 16 | View |
| Dec 04, 2024 | Richard William White | — | 0.00 | $34.01 | -$119.85K | SELL-OPTIONS | 0.00% | 0.00 | Dec 02 | View |
| Nov 26, 2024 | Jacob William Savage | CHIEF MEDICAL OFFICER | 0.00 | $38.80 | -$756.01K | SELL-OPTIONS | 0.00% | 40.41K | Nov 25 | View |
| Nov 19, 2024 | Jacob William Savage | CHIEF MEDICAL OFFICER | 0.00 | $34.75 | -$455.85K | SELL-OPTIONS | 0.00% | 40.41K | Nov 15 | View |
| Nov 05, 2024 | Richard William White | — | 0.00 | $51.49 | -$99.50K | SELL-OPTIONS | 0.00% | 0.00 | Nov 01 - Nov 04 | View |
| Oct 03, 2024 | Richard William White | — | 0.00 | $30.58 | -$8.33K | SELL-OPTIONS | 0.00% | 0.00 | Oct 01 | View |
| Sep 18, 2024 | Jacob William Savage | CHIEF MEDICAL OFFICER | -1.50K | $47.41 | -$71.11K | SELL | -3.58% | 40.41K | Sep 16 | View |
| Sep 05, 2024 | Richard William White | — | 0.00 | $26.52 | -$90.52K | SELL-OPTIONS | 0.00% | 0.00 | Sep 03 | View |
| Sep 04, 2024 | Jacob William Savage | CHIEF MEDICAL OFFICER | -1.50K | $50.59 | -$75.89K | SELL | -3.46% | 41.91K | Sep 03 | View |
| Aug 05, 2024 | Richard William White | — | 0.00 | $26.65 | -$6.75K | SELL-OPTIONS | 0.00% | 0.00 | Aug 01 | View |
| Jul 03, 2024 | Richard William White | — | 0.00 | $27.95 | -$7.27K | SELL-OPTIONS | 0.00% | 0.00 | Jul 01 | View |
| Jun 20, 2024 | Kevin Bitterman | — | 222.22K | $36.00 | $8.00M | BUY | 89.13% | 471.55K | Jun 17 | View |
| Jun 20, 2024 | Mona Ashiya | DIRECTOR | 83.33K | $36.00 | $3.00M | BUY | 54.80% | 235.39K | Jun 17 | View |
| Jun 20, 2024 | ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLCOrbiMed Capital GP VIII LLCOrbiMed Genesis GP LLC | DIRECTOR | 83.33K | $36.00 | $3.00M | BUY | 54.80% | 235.39K | Jun 17 | View |
| Jun 05, 2024 | Richard William White | — | 0.00 | $19.74 | -$63.97K | SELL-OPTIONS | 0.00% | 0.00 | Jun 03 | View |
| May 03, 2024 | Richard William White | — | 0.00 | $19.25 | -$3.77K | SELL-OPTIONS | 0.00% | 0.00 | May 01 | View |
| Apr 15, 2024 | Richard William White | — | 0.00 | $18.36 | -$68.83K | SELL-OPTIONS | 0.00% | 0.00 | Apr 11 | View |
| Mar 07, 2024 | Kevin Bitterman | — | -26.16K | $73.50 | -$1.92M | SELL | -3.47% | 728.50K | Mar 05 | View |
| Jan 25, 2024 | Kevin Bitterman | DIRECTOR | -102.50K | $67.65 | -$6.93M | SELL | -29.13% | 249.33K | Jan 23 | View |
| Jan 25, 2024 | Atlas Venture Fund X LPATLAS VENTURE ASSOCIATES X LPAtlas Venture Associates X LLCAtlas Venture Opportunity Fund I LPAtlas Venture Associates Opportunity I LPAtlas Venture Associates Opportunity I LLCAtlas Venture Opportunity Fund II LPAtlas Venture Associates Opportunity II LPAtlas Venture Associates Opportunity II LLC | 10% OWNER | -150.00K | $67.65 | -$10.15M | SELL | -43.06% | 198.33K | Jan 23 | View |
| Jan 12, 2024 | Kevin Bitterman | DIRECTOR | -20.00K | $64.00 | -$1.28M | SELL | -2.33% | 837.16K | Jan 10 | View |
| Jan 12, 2024 | Atlas Venture Fund X LPATLAS VENTURE ASSOCIATES X LPAtlas Venture Associates X LLCAtlas Venture Opportunity Fund I LPAtlas Venture Associates Opportunity I LPAtlas Venture Associates Opportunity I LLC | 10% OWNER | -50.00K | $64.00 | -$3.20M | SELL | -5.98% | 786.16K | Jan 10 | View |
| Dec 20, 2023 | ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLCOrbiMed Capital GP VIII LLCOrbiMed Genesis GP LLC | DIRECTOR | 0.00 | $48.62 | -$36.62K | SELL-OPTIONS | 0.00% | 224.41K | Dec 18 | View |
| Dec 20, 2023 | Mona Ashiya | DIRECTOR | 0.00 | $48.62 | -$36.62K | SELL-OPTIONS | 0.00% | 224.41K | Dec 18 | View |
| Dec 15, 2023 | Mona Ashiya | DIRECTOR | -433.20K | $56.75 | -$24.58M | SELL | -65.88% | 224.41K | Dec 14 | View |
| Dec 15, 2023 | ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLCOrbiMed Capital GP VIII LLCOrbiMed Genesis GP LLC | DIRECTOR | -433.20K | $56.75 | -$24.58M | SELL | -65.88% | 224.41K | Dec 14 | View |
| Dec 14, 2023 | Kevin Bitterman | DIRECTOR | -76.06K | $61.45 | -$4.67M | SELL | -8.15% | 857.16K | Dec 12 - Dec 14 | View |
| Dec 14, 2023 | Atlas Venture Fund X LPATLAS VENTURE ASSOCIATES X LPAtlas Venture Associates X LLCAtlas Venture Opportunity Fund I LPAtlas Venture Associates Opportunity I LPAtlas Venture Associates Opportunity I LLC | 10% OWNER | -190.16K | $61.45 | -$11.68M | SELL | -19.09% | 806.16K | Dec 12 - Dec 14 | View |
| Dec 14, 2023 | ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLCOrbiMed Capital GP VIII LLCOrbiMed Genesis GP LLC | DIRECTOR | -134.20K | $58.88 | -$7.90M | SELL | -15.57% | 727.81K | Dec 12 - Dec 14 | View |
| Dec 14, 2023 | Mona Ashiya | DIRECTOR | -134.20K | $58.88 | -$7.90M | SELL | -15.57% | 727.81K | Dec 12 - Dec 14 | View |
| Dec 14, 2023 | Richard William White | — | 0.00 | $34.65 | -$1.91M | SELL-OPTIONS | 0.00% | 0.00 | Dec 12 | View |
| Dec 14, 2023 | Joanne Bryce | CHIEF FINANCIAL OFFICER | 0.00 | $33.94 | -$156.44K | SELL-OPTIONS | 0.00% | 2.50K | Dec 12 | View |
| Dec 07, 2023 | Joanne Bryce | CHIEF FINANCIAL OFFICER | -1.26K | $28.51 | -$141.01K | SELL | -33.51% | 2.50K | Dec 05 | View |
| Nov 27, 2023 | Rahul Khara | GENERAL COUNSEL | 0.00 | $33.21 | -$370.43K | SELL-OPTIONS | 0.00% | 0.00 | Nov 22 | View |
| Nov 15, 2023 | Rahul Khara | GENERAL COUNSEL | 0.00 | $32.65 | -$176.03K | SELL-OPTIONS | 0.00% | 0.00 | Nov 14 | View |
| Nov 07, 2023 | Rahul Khara | GENERAL COUNSEL | 0.00 | $32.34 | -$3.53K | SELL-OPTIONS | 0.00% | 0.00 | Nov 03 | View |
| Sep 18, 2023 | Atlas Venture Fund X LPATLAS VENTURE ASSOCIATES X LPAtlas Venture Associates X LLC | 10% OWNER | -357.45K | $53.13 | -$18.99M | SELL | -18.32% | 1.59M | Sep 14 - Sep 16 | View |
| Sep 05, 2023 | Joanne Bryce | CHIEF FINANCIAL OFFICER | 0.00 | $27.82 | -$50.34K | SELL-OPTIONS | 0.00% | 1.26K | Sep 01 | View |
| Aug 17, 2023 | Kevin Bitterman | DIRECTOR | -72.93K | $52.40 | -$3.82M | SELL | -7.25% | 933.22K | Aug 15 | View |
| Aug 16, 2023 | Atlas Venture Fund X LPATLAS VENTURE ASSOCIATES X LPAtlas Venture Associates X LLCAtlas Venture Opportunity Fund I LPAtlas Venture Associates Opportunity I LPAtlas Venture Associates Opportunity I LLC | 10% OWNER | -359.00K | $52.49 | -$18.85M | SELL | -28.92% | 882.22K | Aug 14 - Aug 15 | View |
| Aug 16, 2023 | Jacob William Savage | CHIEF MEDICAL OFFICER | -7.67K | $52.95 | -$406.24K | SELL | -100.00% | 0.00 | Aug 15 | View |
| Aug 11, 2023 | Jacob William Savage | CHIEF MEDICAL OFFICER | -8.27K | $49.83 | -$412.06K | SELL | -51.87% | 7.67K | Aug 09 | View |
| Aug 03, 2023 | Joanne Bryce | CHIEF FINANCIAL OFFICER | 0.00 | $25.46 | -$221.07K | SELL-OPTIONS | 0.00% | 1.26K | Aug 01 | View |
| Jun 30, 2023 | Richard Brian MacDonald | CHIEF INNOVATION OFFICER | -13.92K | $46.90 | -$655.02K | SELL | -51.01% | 13.37K | Jun 28 - Jun 30 | View |
| Jun 30, 2023 | Joanne Bryce | CHIEF FINANCIAL OFFICER | -2.19K | $25.48 | -$495.16K | SELL | -63.50% | 1.26K | Jun 28 | View |
| Jun 30, 2023 | Jacob William Savage | CHIEF MEDICAL OFFICER | -4.38K | $49.98 | -$219.11K | SELL | -21.57% | 15.94K | Jun 28 | View |
| Jun 28, 2023 | Novo Holdings AS | 10% OWNER | -1.25M | $46.10 | -$57.63M | SELL | -53.40% | 1.09M | Jun 28 | View |
| Feb 17, 2023 | Mona Ashiya | DIRECTOR | 108.70K | $23.00 | $2.50M | BUY | 57.06% | 299.20K | Feb 15 | View |
| Feb 17, 2023 | ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLCOrbiMed Capital GP VIII LLCOrbiMed Genesis GP LLC | DIRECTOR | 108.70K | $23.00 | $2.50M | BUY | 57.06% | 299.20K | Feb 15 | View |
| Feb 17, 2023 | AI DMI LLCAccess Industries Holdings LLCACCESS INDUSTRIES MANAGEMENT LLCLen Blavatnik | 10% OWNER | 434.78K | $23.00 | $10.00M | BUY | 16.06% | 3.14M | Feb 15 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.